This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor 1 month ago
MarketsTrading IdeasPre-Market OutlookNewsAnalyst RatingsInitiation
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BMO Capital analyst Sean Dodge initiated coverage on HCA Healthcare Inc (NYSE:HCA) with an Outperform rating and announced a price target of $495. HCA Healthcare closed at $438.12 on Tuesday. See how other analysts view this stock.
- Keybanc analyst Zach Haggerty initiated coverage on Guardian Pharmacy Services Inc (NYSE:GRDN) with an Overweight rating and announced a price target of $52. Guardian Pharmacy shares closed at $44.67 on Tuesday. See how other analysts view this stock.
- Oppenheimer analyst Kristen Owen initiated coverage on Toro Co (NYSE:TTC) with an Outperform rating and announced a price target of $120. Toro closed at $94.52 on Tuesday. See how other analysts view this stock.
- Seaport Global analyst Jay Goldberg initiated coverage on Marvell Technology Inc (NASDAQ:MRVL) with a Buy rating and announced a price target of $270. Marvell Technology shares closed at $262.36 on Tuesday. See how other analysts view this stock.
- BTIG analyst Marie Thibault initiated coverage on Pulse Biosciences Inc (NASDAQ:PLSE) with a Buy rating and announced a price target of $70. Pulse Biosciences closed at $52.69 on Tuesday. See how other analysts view this stock.
Considering buying HCA stock? Here’s what analysts think:
Photo via Shutterstock